CNODES
Multi-provincial drug safety and effectiveness
Study design and statistical analysis for CDA-commissioned studies on familial hypercholesterolemia, severe acne, and COPD.
- Real-World Evidence
- SAS
- Multi-provincial
Pharmacoepidemiologist · PhD Candidate, McGill University
Evaluating the real-world safety and effectiveness of medicines.

I'm a pharmacoepidemiologist with the Canadian Network for Observational Drug Effect Studies (CNODES) and a doctoral researcher in Epidemiology at McGill University. I trained as a pharmacist in Nigeria, earned my MPH at the University of Glasgow as a Chevening Scholar, and now use real-world data to understand how medicines perform for the people who take them.
By the numbers
1st
Global ranking, 2024 ISPE Student Council research proposal competition
49of ~8,000
Chevening awardees from Nigerian applicants (2019)
3countries
Nigeria · Scotland · Canada
5featured
Publications
Current focus
Two strands of real-world evidence work, one national and one doctoral.
CNODES
Study design and statistical analysis for CDA-commissioned studies on familial hypercholesterolemia, severe acne, and COPD.
PhD · McGill University
A population-based retrospective cohort study among postmenopausal breast cancer survivors, using UK CPRD data. FRQS-funded.
The journey
Nigeria
2017
Trained and practised as a pharmacist in hospital and community settings.
Glasgow
2021
Chevening Scholar at the University of Glasgow.
Montreal
2022 – now
Doctoral research and multi-provincial drug safety studies.
Featured research
News
Presented two posters at ISPE 2026 in Milan, Italy.
Presented my doctoral research on the safety of breast cancer treatments at the BE-STEMM 2026 Conference in Ottawa (Canadian Black Scientists Network).
Published the CNODES and Canada's Drug Agency (CDA-AMC) report on PCSK9 inhibitors in familial hypercholesterolemia.
Kind words
I'm always glad to talk about research collaborations, real-world evidence, teaching or mentoring.